Ask AI
Obesity Management During Reproductive Years
Clinical Queries: Expert Insights to Improve Obesity Management During Reproductive Years 

Released: January 20, 2026

Activity

Progress
1
Course Completed

  1. Tchang BG, Mihai AC, Stefanski A, et al. Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program. Obesity (Silver Spring). 2025;33:851-860.
  2. Hurtado MD, Saadedine M, Kapoor E, et al. Weight gain in midlife women. Curr Obes Rep. 2024;13:352-363.
  3. Nadolsky K, Garvey WT, Agarwal M, et al. American Association of Clinical Endocrinology consensus statement: algorithm for the evaluation and treatment of adults with obesity/adiposity-based chronic disease - 2025 update. Endocr Pract. 2025;31:1351-1394.
  4. Wharton S, Lau DCW, Vallis M, et al. Obesity in adults : a clinical practice guideline. CMAJ. 2020;192:E875-E891.
  5. STOP Obesity Alliance. Why Weight? A guide to discussing obesity and health with your patients. stop.publichealth.gwu.edu/sites/g/files/zaxdzs4356/files/2022-05/why-weight-guide-stop-provider-discussion-tool.pdf. Accessed December 11, 2025.
  6. Bannuru RR. Weight stigma and bias: standards of care in overweight and obesity—2025. BMJ Open Diab Res Care. 2025;13:e004962.
  7. Aronne LJ, Horn DB, le Roux CW, et al; SURMOUNT-5 Trial Investigators. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393:26-36.
  8. Andrade MDDH, Dunsmoor-Su R, Huvinen E, et al. Semaglutide reduces body weight regardless of menopause status: STEP and OASIS 4 post hoc analysis. Presented at ObesityWeek 2025. Poster 316.
  9. Semaglutide [prescribing information]. Plainsboro, NJ: Novo Nordisk, Inc.; 2025.
  10. Tirzepatide [prescribing information]. Indianapolis, IN: Lilly USA, LLC; 2025.
  11. Kushner RF, Almandoz JP, Rubino DM. Managing adverse effects of incretin-based medications for obesity. JAMA. 2025;334:822-823
  12. Tirzepatide [product information]. Firenze, Italy: Eli Lilly Italia S.p.A.; 2024.
  13. Tirzepatide [product information]. Toronto, Canada: Eli Lilly Canada Inc.; 2025.